The parallel placebo-controlled study examined the therapeutic effects of dual-target repetitive transcranial magnetic stimulation (rTMS) of the motor cortex (bilaterally) and the left prefrontal cortex (dorsolaterally) on spontaneous and mitogen-stimulating synthesis of pro- and anti-inflammatory cytokines by the blood cells and the level of brain-derived neurotrophic factor (BDNF) in blood serum of patients with Parkinson’s disease. The significantly steeper positive clinical dynamics (assessed by UPRSD scale) observed in rTMS group in comparison with the placebo group was accompanied by a significant drop in spontaneous production of proinflammatory cytokines IFNγ and IL-17A. rTMS produced no significant effect on serum BDNF. The possible mechanisms of rTMS therapeutic action on the level of cytokines associated with neuroinflammation in patients with Parkinson’s disease are discussed.
Similar content being viewed by others
References
Melnikov MV, Belousova OO, Zhetishev RR, Pashenkov МV, Boyko AN. The influence of catecholamines on Th17-cells in multiple sclerosis. Zh. Nevrol. Psikhiatr. 2016;116(10-2):16-20. Russian.
Milyukhina IV, Karpenko MN, Klimenko VM. Clinical parameters and the level of certain cytokines in blood and cerebrospinal fluid of patients with Parkinson’s disease. Klin. Med. 2015;93(1):51-55. Russian.
Aftanas LI, Brack IV, Danilenko KV, Kulikova KI, Dzemidovich SS, Doronin BM. Parkinson’s disease, depression, navigated transcranial magnetic stimulation, dual-target stimulation. Brain Stimulaton. 2017;10(2):486.
Chervyakov AV, Chernyavsky AY, Sinitsyn DO, Piradov MA. Possible mechanisms underlying the therapeutic effects of transcranial magnetic stimulation. Front. Hum. Neurosci. 2015;9:303. doi: https://doi.org/10.3389/fnhum.2015.00303.
Etiévant A, Manta S, Latapy C, Magno LA, Fecteau S, Beaulieu JM. Repetitive transcranial magnetic stimulation induces long-lasting changes in protein expression and histone acetylation. Sci. Rep. 2015;5. ID 16873. doi: https://doi.org/10.1038/srep16873.
Goodwill AM, Lum JAG, Hendy AM, Muthalib M, Johnson L, Albein-Urios N, Teo WP. Using non-invasive transcranial stimulation to improve motor and cognitive function in Parkinson’s disease: a systematic review and meta-analysis. Sci. Rep. 2017;7(1). ID 14840. doi: https://doi.org/10.1038/s41598-017-13260-z.
Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology. 1967;17(5):427-442.
Idova GV, Alperina EL, Cheido MA. Contribution of brain dopamine, serotonin and opioid reсeptors in the mechanisms of neuroimmunomodulation: evidence from pharmacological analysis. Int. Immunopharmacol. 2012;12(4):618-625.
Khedr EM, Rothwell JC, Shawky OA, Ahmed MA, Foly N, Hamdy A. Dopamine levels after repetitive transcranial magnetic stimulation of motor cortex in patients with Parkinson’s disease: preliminary results. Mov. Disord. 2007;22(7):1046-1050.
Matsumoto A, Ohta N, Goto Y, Kashiwa Y, Yamamoto S, Fujino Y. Haloperidol suppresses murine dendritic cell maturation and priming of the T helper 1-type immune response. Anesth. Analg. 2015;120(4):895-902.
Mount MP, Lira A, Grimes D, Smith PD, Faucher S, Slack R, Anisman H, Hayley S, Park DS. Involvement of interferongamma in microglial-mediated loss of dopaminergic neurons. J. Neurosci. 2007;27(12):3328-3337.
Okada K, Matsunaga K, Yuhi T, Kuroda E, Yamashita U, Tsuji S. The long-term high-frequency repetitive transcranial magnetic stimulation does not induce mRNA expression of inflammatory mediators in the rat central nervous system. Brain Res. 2002;957(1):37-41.
Schaller G, Sperling W, Richter-Schmidinger T, Mühle C, Heberlein A, Maihöfner C, Kornhuber J, Lenz B. Serial repetitive transcranial magnetic stimulation (rTMS) decreases BDNF serum levels in healthy male volunteers. J. Neural Transm. (Vienna). 2014;121(3):307-313.
Tahmasebinia F, Pourgholaminejad A. The role of Th17 cells in auto-inflammatory neurological disorders. Prog. Neuropsychopharmacol. Biol. Psychiatry. 2017;79(Pt B):408-416.
Yang X, Song L, Liu Z. The effect of repetitive transcranial magnetic stimulation on a model rat of Parkinson’s disease. Neuroreport. 2010;21(4):268-272.
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 165, No. 2, pp. 155-159, February, 2018
Rights and permissions
About this article
Cite this article
Aftanas, L.I., Gevorgyan, M.M., Zhanaeva, S.Y. et al. Therapeutic Effects of Repetitive Transcranial Magnetic Stimulation (rTMS) on Neuroinflammation and Neuroplasticity in Patients with Parkinson’s Disease: a Placebo-Controlled Study. Bull Exp Biol Med 165, 195–199 (2018). https://doi.org/10.1007/s10517-018-4128-4
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10517-018-4128-4